Description
Acalabrutinib capsules are Bruton’s tyrosine kinase (BTK) inhibitors used to treat certain B-cell malignancies like mantle cell lymphoma and chronic lymphocytic leukemia. They block BTK signaling, reducing cancer cell survival and spread, offering targeted therapy with fewer side effects than traditional chemotherapy.